Dow Chemical Company’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Dow Chemical Company’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,250	Closed	-$31K	–	18
2019 Q2	$31K	Hold	3,250	–	–	﹤0.01%	16
2019 Q1	$87K	Hold	3,250	–	–	0.01%	18
2018 Q4	$73K	Hold	3,250	–	–	0.01%	18
2018 Q3	$179K	Hold	3,250	–	–	0.02%	18
2018 Q2	$232K	Hold	3,250	–	–	0.08%	16
2018 Q1	$200K	Hold	3,250	–	–	0.07%	16
2017 Q4	$410K	Hold	3,250	–	–	0.1%	18
2017 Q3	$445K	Hold	3,250	–	–	0.11%	19
2017 Q2	$463K	Hold	3,250	–	–	0.05%	25
2017 Q1	$597K	Hold	3,250	–	–	0.07%	22
2016 Q4	$249K	Hold	3,250	–	–	0.03%	27
2016 Q3	$249K	Hold	3,250	–	–	0.02%	27
2016 Q2	$280K	Hold	3,250	–	–	0.03%	24
2016 Q1	$301K	Hold	3,250	–	–	0.03%	25
2015 Q4	$652K	Hold	3,250	–	–	0.06%	23
2015 Q3	$485K	Buy	+3,250	New	+$2.39M	0.04%	85
2014 Q3	–	Sell	-1,235	Closed	-$333K	–	108
2014 Q2	$333K	Buy	+1,235	New	+$265K	0.03%	88

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dow Chemical Company's TTPH Position: Q3 2019 in Review

Dow Chemical Company sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 3,250 shares — an estimated $31K sold.

Dow Chemical Company first reported a position in TTPH in Q2 2014 and held it in 17 quarters. The position peaked at $652K in Q4 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

Dow Chemical Company reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Dow Chemical Company sold 3,250 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $31K.
Dow Chemical Company first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2014 and held it in 17 quarters.
Dow Chemical Company's Tetraphase Pharmaceuticals, Inc. position peaked at $652K in Q4 2015.
26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Dow Chemical Company's 13F filing for Q3 2019, filed 8 Nov 2019.